Insperity, Inc. 8-K Filing

FAQ

Key Financial Figures

• $500,000 — y for each participant's claim costs to $500,000, $750,000, or $1,000,000 per year; revi
• $750,000 — participant's claim costs to $500,000, $750,000, or $1,000,000 per year; revises certai
• $1,000,000 — s claim costs to $500,000, $750,000, or $1,000,000 per year; revises certain administrativ

Filing Documents

• nsp-20251103.htm (8-K) — 26KB
• a09302025-ex1012026insperi.htm (EX-10.1) — 29KB
• a09302025-ex991earningsrel.htm (EX-99.1) — 314KB
• image_0.jpg (GRAPHIC) — 44KB
• 0001000753-25-000104.txt ( ) — 594KB
• nsp-20251103.xsd (EX-101.SCH) — 2KB
• nsp-20251103_def.xml (EX-101.DEF) — 6KB
• nsp-20251103_lab.xml (EX-101.LAB) — 26KB
• nsp-20251103_pre.xml (EX-101.PRE) — 15KB
• nsp-20251103_htm.xml (XML) — 3KB

01. Entry into a Material Definitive Agreement

Item 1.01. Entry into a Material Definitive Agreement. On November 3, 2025, a subsidiary of Insperity, Inc. (the "Company") entered into an amendment to its arrangement with UnitedHealthcare related to its medical coverage (the "Amendment"). The Amendment includes additional expected cost savings starting in 2026 and extends the arrangement through 2028; provides the Company with the option to annually elect to limit its responsibility for each participant's claim costs to $500,000, $750,000, or $1,000,000 per year; revises certain administrative costs payable by the Company; and adds additional volume-based incentives, subject to certain conditions. The other previously disclosed material items remain unchanged. The foregoing summary is qualified in its entirety by reference to the agreement, a copy of which is filed as Exhibit 10.1 to this Form 8-K and is incorporated in this Item 1.01 by reference. A copy of the Company's press release announcing this amendment is attached as Exhibit 99.1.

02. Results of Operations and Financial Condition

Item 2.02. Results of Operations and Financial Condition. On November 3, 2025, Insperity, Inc. issued a press release announcing the company's financial and operating results for the quarter ended September 30, 2025. A copy of the press release is furnished as Exhibit 99.1 hereto and incorporated by reference. The information in Item 2.02 of this Current Report on Form 8-K, including Exhibit 99.1 attached hereto, is being furnished to the SEC and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section. This information shall not be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

01. Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits. (d) Exhibits 10.1 (+) Letter Agreement by and between Insperity Holdings, Inc. and UnitedHealthcare Insurance Company entered into as of November 3, 2025. 99.1 — Press release regarding financial and operating results issued by Insperity, Inc. on November 3, 2025. 104 Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document. (+) Certain portions of the exhibit have been omitted pursuant to Item 601(b)(10) of Regulation S-K. The omitted information is (i) not material and (ii) the type of information the Company treats as private or confidential.

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. INSPERITY, INC. By: /s/ Christian P. Callens Christian P. Callens Senior Vice President of Legal, General Counsel & Secretary Date: November 3, 2025

View Full Filing

View this 8-K filing on SEC EDGAR